These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27876004)

  • 1. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.
    Groom KM; McCowan LM; Stone PR; Chamley LC; McLintock C;
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):367. PubMed ID: 27876004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial.
    Groom KM; McCowan LM; Mackay LK; Lee AC; Said JM; Kane SC; Walker SP; van Mens TE; Hannan NJ; Tong S; Chamley LW; Stone PR; McLintock C;
    Am J Obstet Gynecol; 2017 Mar; 216(3):296.e1-296.e14. PubMed ID: 28153659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
    Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
    Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
    McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis.
    Mastrolia SA; Novack L; Thachil J; Rabinovich A; Pikovsky O; Klaitman V; Loverro G; Erez O
    Thromb Haemost; 2016 Oct; 116(5):868-878. PubMed ID: 27440387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis.
    Kontovazainitis CG; Gialamprinou D; Katsaras GN; Pouliakis A; Theodoridis T; Mitsiakos G
    Am J Perinatol; 2023 Dec; 40(16):1745-1764. PubMed ID: 35235957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Growth Assessment Protocol (GAP) for antenatal detection of small for gestational age: The DESiGN cluster randomised trial.
    Vieira MC; Relph S; Muruet-Gutierrez W; Elstad M; Coker B; Moitt N; Delaney L; Winsloe C; Healey A; Coxon K; Alagna A; Briley A; Johnson M; Page LM; Peebles D; Shennan A; Thilaganathan B; Marlow N; McCowan L; Lees C; Lawlor DA; Khalil A; Sandall J; Copas A; Pasupathy D;
    PLoS Med; 2022 Jun; 19(6):e1004004. PubMed ID: 35727800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
    Haddad B; Winer N; Chitrit Y; Houfflin-Debarge V; Chauleur C; Bages K; Tsatsaris V; Benachi A; Bretelle F; Gris JC; Bastuji-Garin S;
    Obstet Gynecol; 2016 Nov; 128(5):1053-1063. PubMed ID: 27741174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP).
    Mazarico E; Peguero A; Camprubí M; Rovira C; Gomez Roig MD; Oros D; Ibáñez-Burillo P; Schoorlemmer J; Masoller N; Tàssies MD; Figueras F
    BMJ Open; 2018 Oct; 8(10):e020501. PubMed ID: 30355790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
    Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J
    BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.